Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$400M |
| 2 |
Citigroup
C
|
+$395M |
| 3 |
CELG
Celgene Corp
CELG
|
+$360M |
| 4 |
Amazon
AMZN
|
+$347M |
| 5 |
RTX Corp
RTX
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$397M |
| 2 |
Salesforce
CRM
|
+$355M |
| 3 |
TSS
Total System Services, Inc.
TSS
|
+$354M |
| 4 |
ULTI
Ultimate Software Group Inc
ULTI
|
+$349M |
| 5 |
Autodesk
ADSK
|
+$313M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.61% |
| 2 | Financials | 4.93% |
| 3 | Healthcare | 4% |
| 4 | Consumer Discretionary | 3.82% |
| 5 | Industrials | 3.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7301
PUT
Kulicke & Soffa
KLIC
$5.19B
| $318K | ﹤0.01% |
14,100
-4,700
| -25% | -$103K |
|
7302
PUT
NNN REIT
NNN
$8.83B
| $318K | ﹤0.01% |
+6,000
| New | +$320K |
|
7303
PUT
Omnicell
OMCL
$1.7B
| $318K | ﹤0.01% |
3,700
+900
| +32% | +$73.1K |
|
|
CLGX
7304
CALL
DELISTED
Corelogic, Inc.
CLGX
| $318K | ﹤0.01% |
7,600
-700
| -8% | -$28.6K |
|
|
ADAP
7305
DELISTED
Adaptimmune Therapeutics
ADAP
| $317K | ﹤0.01% |
78,755
+6,089
| +8% | +$24.8K |
|
7306
PUT
Orthofix Medical
OFIX
$421M
| $317K | ﹤0.01% |
6,000
-13,600
| -69% | -$723K |
|
7307
CALL
VanEck Pharmaceutical ETF
PPH
$985M
| $317K | ﹤0.01% |
5,400
-6,100
| -53% | -$353K |
|
7308
PUT
Tidewater
TDW
$4.69B
| $317K | ﹤0.01% |
+13,500
| New | +$310K |
|
7309
PUT
Energous
WATT
$86M
| $317K | ﹤0.01% |
121
-143
| -54% | -$418K |
|
|
FLG
7310
PUT
Flagstar Bank National Association
FLG
$5.92B
| $317K | ﹤0.01% |
10,600
-10,667
| -50% | -$344K |
|
|
GLCN
7311
DELISTED
VanEck China Growth Leaders ETF
GLCN
| $317K | ﹤0.01% |
7,890
-1,153
| -13% | -$46K |
|
|
KDMN
7312
DELISTED
Kadmon Holdings, Inc.
KDMN
| $317K | ﹤0.01% |
154,035
+91,244
| +145% | +$203K |
|
|
CBPO
7313
DELISTED
China Biologic Products Holdings, Inc.
CBPO
| $317K | ﹤0.01% |
3,325
-1,570
| -32% | -$148K |
|
7314
CALL
American States Water
AWR
$3.53B
| $316K | ﹤0.01% |
4,200
-1,800
| -30% | -$130K |
|
7315
InflaRx
IFRX
$301M
| $316K | ﹤0.01% |
99,935
+4,840
| +5% | +$153K |
|
7316
CALL
KRONOS Worldwide
KRO
$975M
| $316K | ﹤0.01% |
20,600
-20,900
| -50% | -$290K |
|
7317
QCR Holdings
QCRH
$1.74B
| $316K | ﹤0.01% |
+9,069
| New | +$309K |
|
7318
PUT
TE Connectivity
TEL
$62.6B
| $316K | ﹤0.01% |
3,300
-25,000
| -88% | -$2.26M |
|
7319
PUT
TherapeuticsMD
TXMD
$24M
| $316K | ﹤0.01% |
2,434
+562
| +30% | +$101K |
|
7320
CALL
Veracyte
VCYT
$3.32B
| $316K | ﹤0.01% |
+11,100
| New | +$277K |
|
7321
CALL
Wave Life Sciences
WVE
$1.07B
| $316K | ﹤0.01% |
12,100
-6,900
| -36% | -$193K |
|
|
GARD
7322
DELISTED
Reality Shares DIVCON Dividend Guard ETF
GARD
| $316K | ﹤0.01% |
+13,056
| New | +$312K |
|
7323
PUT
Star Bulk Carriers
SBLK
$3.24B
| $315K | ﹤0.01% |
32,600
-8,100
| -20% | -$65K |
|
7324
CALL
Theravance Biopharma
TBPH
$881M
| $315K | ﹤0.01% |
+19,300
| New | +$391K |
|
7325
PUT
Universal Insurance Holdings
UVE
$1.2B
| $315K | ﹤0.01% |
11,300
-4,000
| -26% | -$117K |
|
Similar funds
Ken Griffin's Q2 2019 Portfolio in Review
As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.
By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.
- Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
- Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
- Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
- Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
- Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
- Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
- Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.
Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.